Kestra Medical Technologies, Ltd. Common Stock Working Capital to Net Assets Ratio
Kestra Medical Technologies, Ltd. Common Stock working capital to net assets ratio. Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a Working Capital to Net Assets ratio of 94.1% as of January 2026. Working capital of $271.13 Million (current assets of $314.06 Million minus current liabilities of $42.93 Million) is measured against net assets of $287.99 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Kestra Medical Technologies, Ltd. Common to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
Working capital to net assets ratio of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. This chart shows how Kestra Medical Technologies, Ltd. Common Stock's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2025. As of January 2026, the ratio stands at 94.1%, reflecting working capital of $271.13 Million against net assets of $287.99 Million USD. See Kestra Medical Technologies, Ltd. Common (KMTS) liquidity interval to measure how many days the company can operate on defensive assets alone.
Kestra Medical Technologies, Ltd. Common Stock Working Capital to Net Assets Ratio by Year (2020–2025)
Kestra Medical Technologies, Ltd. Common Stock working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Kestra Medical Technologies, Ltd. Common balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 105.8% | $217.35 Million | $205.41 Million | $255.33 Million | $37.98 Million | ▲ +97.2 pp |
| 2024 | 8.6% | $-18.06 Million | $-209.38 Million | $14.91 Million | $32.97 Million | ▼ -7.0 pp |
| 2023 | 15.6% | $-18.32 Million | $-117.58 Million | $18.42 Million | $36.74 Million | ▼ -1093.6 pp |
| 2021 | 1109.2% | $19.59 Million | $1.77 Million | $26.20 Million | $6.61 Million | ▲ +1053.4 pp |
| 2020 | 55.8% | $2.15 Million | $3.86 Million | $6.17 Million | $4.02 Million | — |